Journal Of Clinical Oncology (jco) Podcast
No Advantage to Combining Cetuximab with 5FU, Leucovorin, and Oxaliplatin in Metastatic Colorectal Cancer
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:06:44
- Mas informaciones
Informações:
Sinopsis
This podcast reviews a negative phase III clinical trial of cetuximab combined with chemotherapy in first-line metastatic colorectal cancer and focuses on the interaction of targeted therapy combined with chemotherapy.
